Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
16.24
+0.48 (3.05%)
At close: Jun 26, 2026, 4:00 PM EDT
16.30
+0.06 (0.37%)
After-hours: Jun 26, 2026, 6:51 PM EDT
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Tandem Diabetes Care stock have an average target of 29.62, with a low estimate of 15.5 and a high estimate of 55. The average target predicts an increase of 82.39% from the current stock price of 16.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tandem Diabetes Care stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 9 | 9 | 9 | 10 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 14 | 14 | 11 | 11 | 11 | 10 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 24 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Deutsche Bank No rating | Deutsche Bank | Hold Initiates $16 | Hold | Initiates | $16 | -4.56% | Jun 23, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $25 | Hold | Maintains | $25 | +53.94% | Jun 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Upgrades $21 → $27 | Buy | Upgrades | $21 → $27 | +66.26% | Jun 1, 2026 |
| Citi | Citi | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +4.68% | May 28, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | +29.31% | May 27, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 1.01B
Increased by 5.80%
Revenue Next Year
1.20B
from 1.07B
Increased by 12.24%
EPS This Year
-0.71
from -2.58
EPS Next Year
0.08
from -0.71
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | 1.3B | |
| Avg | 1.1B | 1.2B | |
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5% | 17.9% | |
| Avg | 5.8% | 12.2% | |
| Low | 5.0% | 6.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.41 | 0.58 | |
| Avg | -0.71 | 0.08 | |
| Low | -1.02 | -0.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.